146 related articles for article (PubMed ID: 9724028)
21. Cytotoxic activity of a recombinant fusion protein between insulin-like growth factor I and Pseudomonas exotoxin.
Prior TI; Helman LJ; FitzGerald DJ; Pastan I
Cancer Res; 1991 Jan; 51(1):174-80. PubMed ID: 1846308
[TBL] [Abstract][Full Text] [Related]
22. Two primitive neuroectodermal tumor cell lines require an activated insulin-like growth factor I receptor for growth in vitro.
Chin LS; Yung WK; Raffel C
Neurosurgery; 1996 Dec; 39(6):1183-90. PubMed ID: 8938773
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation.
Endres K; Anders A; Kojro E; Gilbert S; Fahrenholz F; Postina R
Eur J Biochem; 2003 Jun; 270(11):2386-93. PubMed ID: 12755693
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers.
Moxham CP; Duronio V; Jacobs S
J Biol Chem; 1989 Aug; 264(22):13238-44. PubMed ID: 2546949
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of the insulin-like growth factor I prohormone processing site.
Duguay SJ; Lai-Zhang J; Steiner DF
J Biol Chem; 1995 Jul; 270(29):17566-74. PubMed ID: 7615562
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor-mediated phosphorylation and protooncogene induction in Madin-Darby canine kidney cells.
Hauguel-de Mouzon S; Kahn CR
Mol Endocrinol; 1991 Jan; 5(1):51-60. PubMed ID: 1708099
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells.
Neely EK; Rosenfeld RG
Endocrinology; 1992 Feb; 130(2):985-93. PubMed ID: 1370799
[TBL] [Abstract][Full Text] [Related]
28. An altered IGF-I receptor is present in human leukemic cells.
Kellerer M; Obermaier-Kusser B; Ermel B; Wallner U; Häring HU; Petrides PE
J Biol Chem; 1990 Jun; 265(16):9340-5. PubMed ID: 1693149
[TBL] [Abstract][Full Text] [Related]
29. Furin regulates both the activation of Pseudomonas exotoxin A and the Quantity of the toxin receptor expressed on target cells.
Gu M; Gordon VM; Fitzgerald DJ; Leppla SH
Infect Immun; 1996 Feb; 64(2):524-7. PubMed ID: 8550202
[TBL] [Abstract][Full Text] [Related]
30. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
31. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D
Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783
[TBL] [Abstract][Full Text] [Related]
32. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
Arteaga CL; Osborne CK
Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
[TBL] [Abstract][Full Text] [Related]
33. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody.
Wang Y; Hailey J; Williams D; Wang Y; Lipari P; Malkowski M; Wang X; Xie L; Li G; Saha D; Ling WL; Cannon-Carlson S; Greenberg R; Ramos RA; Shields R; Presta L; Brams P; Bishop WR; Pachter JA
Mol Cancer Ther; 2005 Aug; 4(8):1214-21. PubMed ID: 16093437
[TBL] [Abstract][Full Text] [Related]
35. Processing of transforming growth factor beta 1 precursor by human furin convertase.
Dubois CM; Laprise MH; Blanchette F; Gentry LE; Leduc R
J Biol Chem; 1995 May; 270(18):10618-24. PubMed ID: 7737999
[TBL] [Abstract][Full Text] [Related]
36. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved.
Pandini G; Frasca F; Mineo R; Sciacca L; Vigneri R; Belfiore A
J Biol Chem; 2002 Oct; 277(42):39684-95. PubMed ID: 12138094
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor-I receptors in human glial tumors.
Merrill MJ; Edwards NA
J Clin Endocrinol Metab; 1990 Jul; 71(1):199-209. PubMed ID: 2164527
[TBL] [Abstract][Full Text] [Related]
38. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases.
Gordon VM; Klimpel KR; Arora N; Henderson MA; Leppla SH
Infect Immun; 1995 Jan; 63(1):82-7. PubMed ID: 7806387
[TBL] [Abstract][Full Text] [Related]
39. des-(1-3)-IGF-I, an insulin-like growth factor analog used to mimic a potential IGF-II autocrine loop, promotes the differentiation of human colon-carcinoma cells.
Remacle-Bonnet M; Garrouste F; el Atiq F; Roccabianca M; Marvaldi J; Pommier G
Int J Cancer; 1992 Dec; 52(6):910-7. PubMed ID: 1281142
[TBL] [Abstract][Full Text] [Related]
40. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.
Pommier GJ; Garrouste FL; el Atiq F; Roccabianca M; Marvaldi JL; Remacle-Bonnet MM
Cancer Res; 1992 Jun; 52(11):3182-8. PubMed ID: 1375536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
